Autopsy report · NCT02460107

Botulinum Toxin Type A for Neuropathic Pain in Patients With Diabetic Peripheral Polyneuropathy

“Enrolling failure (lack of participants)”

The sponsor’s own words in the registry.

Life of this trial

• Ran for about 1 year 8 months before it stopped.
• 9 participants enrolled.
• No results are posted on the registry.

Vital statistics

Status

Terminated

Phase

Early Phase 1

Sponsor

Catholic University of Korea Saint Paul's Hospital

Sponsor type

University, hospital or other

Conditions

Neuralgia

Interventions

Botulinum toxin type A; Normal saline

Participants

9

Sites

1

Countries

South Korea

Trials that died the same way

• Early Rehabilitation for Breast Cancer - A Randomized Control Trial
  “Lack of enrolled participants” (79% match in meaning)
• Neoadjuvant HAIC of TACE Plus Donafenib in BCLC B Stage HCC: a Multi-center Randomized Controlled Trial.
  “Difficult to enroll participants” (77% match in meaning)
• Post Operative Delirium Study
  “Participants were unable to be enrolled” (75% match in meaning)
• Surgical PA-LAA Shunting: a Feasibility Study
  “Failure to enroll” (73% match in meaning)
• Efficacy and Safety of Empagliflozin in NODAT
  “Difficult in enrolling suitable participants” (73% match in meaning)

Look deeper

• The official registry record (the source of truth)
• Record history: every change the sponsor made
• Open it in the database

Everything here comes from the current ClinicalTrials.gov record. The timeline uses the record’s dates; dates marked planned are the sponsor’s plans. The cause of death is an automatic, unverified label. This is research information, not medical advice.